Beyond the Price Tag: What Generic Drug Tariffs Could Mean for Patients’ Access to Medication

Editor's Note: Patient Worthy is honored to share this article, originally written by Renzo Luzzatti, President and CEO of US-Rx Care. The White House recently announced intent to impose tariffs…

Continue Reading Beyond the Price Tag: What Generic Drug Tariffs Could Mean for Patients’ Access to Medication

FDA Announces Nationwide Recall of Certain Thyroid Medication Due to Excess Potency Risk

As reported on The Hill, Vitruvias Therapeutics has initiated a voluntary nationwide recall of a specific lot of thyroid medication after testing indicated the tablets may contain higher-than-labeled potency, according…

Continue Reading FDA Announces Nationwide Recall of Certain Thyroid Medication Due to Excess Potency Risk